S. Shalapour

Immunology · 2015–2018

A researcher in the Science corpus: 2 papers; trusts 20 researchers and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

Whom S. Shalapour trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. M. Karin
  2. D. Hanahan
  3. A. Schietinger
  4. S. Grivennikov
  5. Lisa M. Coussens
  6. J. Terzic
  7. D. Mittal
  8. Sky W. Brubaker
  9. R. Weinberg
  10. P. Greenberg

Who trusts S. Shalapour overall

  1. Yiping Yang

Papers from S. Shalapour's perspective

Ordered by how strongly the researchers S. Shalapour trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Hallmarks of cancer: the next generation. (Cell)
  2. Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer. (Cancer Research)
  3. IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion. (Genes & Development)
  4. An immune-active tumor microenvironment favors clinical response to ipilimumab (Cancer Immunology and Immunotherapy)
  5. Genetic basis for clinical response to CTLA-4 blockade in melanoma. (New England Journal of Medicine)
  6. Tolerance and Exhaustion: Defining Mechanisms of T cell Dysfunction (Trends in immunology)
  7. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease (Nature)
  8. Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet? (Science)
  9. Nuclear factor-κB in cancer development and progression (Nature)
  10. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth (Nature)

Their papers